Details
| Stereochemistry | MIXED |
| Molecular Formula | C23H28N4O11S |
| Molecular Weight | 568.554 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 3 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(COC(N)=O)=C(N2C1=O)C(=O)OC(C)OC(=O)C(C)(C)OC)C3=CC=CO3
InChI
InChIKey=MGYPWVCKENORQX-KMMUMHRISA-N
InChI=1S/C23H28N4O11S/c1-11(38-21(31)23(2,3)33-4)37-20(30)16-12(9-36-22(24)32)10-39-19-15(18(29)27(16)19)25-17(28)14(26-34-5)13-7-6-8-35-13/h6-8,11,15,19H,9-10H2,1-5H3,(H2,24,32)(H,25,28)/b26-14-/t11?,15-,19-/m1/s1
Cefuroxime Pivoxetil is an ester prodrug of cefuroxime, a semisynthetic, broad-spectrum, beta-lactamase-resistant, second-generation cephalosporin with antibacterial activity. Cefuroxime binds to and inactivates penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. PBPs are enzymes involved in the terminal stages of assembling the bacterial cell wall and in reshaping the cell wall during growth and division. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C357
Created by
admin on Mon Mar 31 18:31:52 GMT 2025 , Edited by admin on Mon Mar 31 18:31:52 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000055322
Created by
admin on Mon Mar 31 18:31:52 GMT 2025 , Edited by admin on Mon Mar 31 18:31:52 GMT 2025
|
PRIMARY | |||
|
100680-33-9
Created by
admin on Mon Mar 31 18:31:52 GMT 2025 , Edited by admin on Mon Mar 31 18:31:52 GMT 2025
|
PRIMARY | |||
|
6321417
Created by
admin on Mon Mar 31 18:31:52 GMT 2025 , Edited by admin on Mon Mar 31 18:31:52 GMT 2025
|
PRIMARY | |||
|
DTXSID5022776
Created by
admin on Mon Mar 31 18:31:52 GMT 2025 , Edited by admin on Mon Mar 31 18:31:52 GMT 2025
|
PRIMARY | |||
|
CHEMBL1697786
Created by
admin on Mon Mar 31 18:31:52 GMT 2025 , Edited by admin on Mon Mar 31 18:31:52 GMT 2025
|
PRIMARY | |||
|
LR90117565
Created by
admin on Mon Mar 31 18:31:52 GMT 2025 , Edited by admin on Mon Mar 31 18:31:52 GMT 2025
|
PRIMARY | |||
|
567
Created by
admin on Mon Mar 31 18:31:52 GMT 2025 , Edited by admin on Mon Mar 31 18:31:52 GMT 2025
|
PRIMARY | |||
|
C76178
Created by
admin on Mon Mar 31 18:31:52 GMT 2025 , Edited by admin on Mon Mar 31 18:31:52 GMT 2025
|
PRIMARY | |||
|
X-73
Created by
admin on Mon Mar 31 18:31:52 GMT 2025 , Edited by admin on Mon Mar 31 18:31:52 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD